Effect of Transcutaneous Vagus Nerve Stimulation in Erosive Hand Osteoarthritis: Results from a Pilot Trial
- PMID: 35207369
- PMCID: PMC8878516
- DOI: 10.3390/jcm11041087
Effect of Transcutaneous Vagus Nerve Stimulation in Erosive Hand Osteoarthritis: Results from a Pilot Trial
Abstract
Beyond its effect on vegetative functions, the activation of the vagus nerve inhibits inflammation and reduces pain signaling. The aim of this open-label pilot study was to determine the efficacy and tolerance of transcutaneous auricular VNS (taVNS) on erosive hand osteoarthritis (EHOA) symptoms. Symptomatic EHOA patients with hand pain VAS ≥ 40/100 mm and ≥1 interphalangeal swollen joint(s) were included. The taVNS was performed for 4 weeks using an auricular electrode applied one hour per day and connected to a TENS device with pre-established settings. Clinical efficacy was evaluated by changes between baseline and at 4 weeks with hand pain VAS and the functional index FIHOA score, using a Wilcoxon t-test. The treatment tolerance was also evaluated. Eighteen patients (median age 69 years old, 83% women) were analyzed. At baseline, hand pain VAS was 60 mm [IQR 50; 78.2] and FIHOA 15 [10.7; 20.2]. After 4 weeks, taVNS significantly reduced hand pain VAS, with a median decrease of 23.5 mm [7.7; 37.2] (p = 0.001), as well as FIHOA, with a median decrease of 2 points [0.75; 5.2] (p = 0.01). No serious adverse events were reported. One patient stopped taVNS because of auricular discomfort. This first proof-of-concept trial indicated that taVNS is feasible and may decrease joint inflammation and clinical symptoms in EHOA, arguing for a randomized controlled study versus sham stimulation.
Keywords: erosive hand osteoarthritis; function; inflammation; pain; vagus nerve stimulation.
Conflict of interest statement
The authors declare that there are no conflict of interest.
Figures
References
-
- Kloppenburg M., Kroon F.P., Blanco F.J., Doherty M., Dziedzic K.S., Greibrokk E., Haugen I.K., Herrero-Beaumont G., Jonsson H., Kjeken I., et al. 2018 Update of the EULAR Recommendations for the Management of Hand Osteoarthritis. Ann. Rheum. Dis. 2019;78:16–24. doi: 10.1136/annrheumdis-2018-213826. - DOI - PubMed
-
- Richette P., Latourte A., Sellam J., Wendling D., Piperno M., Goupille P., Pers Y.-M., Eymard F., Ottaviani S., Ornetti P., et al. Efficacy of Tocilizumab in Patients with Hand Osteoarthritis: Double Blind, Randomised, Placebo-Controlled, Multicentre Trial. Ann. Rheum. Dis. 2020;80:349–355. doi: 10.1136/annrheumdis-2020-218547. - DOI - PubMed
LinkOut - more resources
Full Text Sources
